For the past 15 years, DIA China Annual Meeting has became the must-attend conference for all life science professionals working in lifecycle drug development, from discovery to marketed use in Asia. 2023 DIA China Annual Meeting had attracted more than 6000+ life cycle drug development professionals and over 490+ exhibitors from MNC & Local Pharma Companies, Clinical Development Sites and CROs/CDMOs globally to be part of the conference in June. It encourages open collaboration by bringing together representatives from the entire spectrum of the life science landscape and facilitating crucial multidisciplinary discussions across several tracks, such as Regulatory Science, Patient Centered Clinical Drug Development, Digital Health, Pharmacovigilance and Drug Safety, Clinical Operations, Advanced Therapy, Real-Evidence and Data Standards and many more.

        The upcoming DIA China 2024 Meeting will be held from May 16th – 19th in an in-person conference format in Suzhou, will continue to bring the key focuses on Regulatory Innovation, Science & Technology Innovation, and Talent Innovation to forward looking the trends of globalization and localization of drug development & innovation.

        Participants will find an array of diverse perspectives across our over 100 scientific sessions in 15 educational themes, dedicated communication, networking, knowledge sharing opportunities, and a dynamic exhibit hall. By joining us, you will be immersed in conversations with KOLs from all over the world with the same goal – to advance innovation and collaboration that protect people health.